Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arata Azuma

Showing results (211-220 of 221) with videos related to

Pageof 23
Sort By:
Chest|May 4, 2020
When the Game Changes: Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 PandemicNadera J Sweiss, Peter Korsten, Huzaefah J Syed, et al.
American Journal of Respiratory and Critical Care Medicine|September 29, 2023
Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice GuidelineGanesh Raghu, Sydney B Montesi, Richard M Silver, et al.
Respiratory Investigation|July 8, 2018
Japanese guideline for the treatment of idiopathic pulmonary fibrosisSakae Homma, Masashi Bando, Arata Azuma, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 23, 2014
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical toolMarc A Judson, Ulrich Costabel, Marjolein Drent, et al.
Respiratory Investigation|December 29, 2022
Design and rationale of the Japanese Idiopathic Interstitial Pneumonias (JIPS) RegistryRyo Okuda, Takashi Ogura, Shu Hisata, et al.
ERJ Open Research|March 5, 2025
The interstitial lung disease patient pathway: from referral to diagnosisGraham Lough, Rayid Abdulqawi, Gina Amanda, et al.
American Journal of Respiratory and Critical Care Medicine|January 10, 2020
Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled TrialYasuhiro Kondoh, Arata Azuma, Yoshikazu Inoue, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 11, 2019
JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis　- Digest VersionFumio Terasaki, Arata Azuma, Toshihisa Anzai, et al.
Scientific Reports|December 27, 2023
A prospective cohort study of periostin as a serum biomarker in patients with idiopathic pulmonary fibrosis treated with nintedanibMasaki Okamoto, Kiminori Fujimoto, Takeshi Johkoh, et al.
Respiratory Investigation|March 18, 2025
Prognostic prediction for newly diagnosed patients with idiopathic interstitial pneumonia: JIPS Registry (NEJ030)Ryo Okuda, Takashi Ogura, Shu Hisata, et al.
Pageof 23

Showing results (211-220 of 221) with videos related to

Sort By:
Pageof 23
Chest|May 4, 2020
When the Game Changes: Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 PandemicNadera J Sweiss, Peter Korsten, Huzaefah J Syed, et al.
American Journal of Respiratory and Critical Care Medicine|September 29, 2023
Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice GuidelineGanesh Raghu, Sydney B Montesi, Richard M Silver, et al.
Respiratory Investigation|July 8, 2018
Japanese guideline for the treatment of idiopathic pulmonary fibrosisSakae Homma, Masashi Bando, Arata Azuma, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 23, 2014
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical toolMarc A Judson, Ulrich Costabel, Marjolein Drent, et al.
Respiratory Investigation|December 29, 2022
Design and rationale of the Japanese Idiopathic Interstitial Pneumonias (JIPS) RegistryRyo Okuda, Takashi Ogura, Shu Hisata, et al.
ERJ Open Research|March 5, 2025
The interstitial lung disease patient pathway: from referral to diagnosisGraham Lough, Rayid Abdulqawi, Gina Amanda, et al.
American Journal of Respiratory and Critical Care Medicine|January 10, 2020
Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled TrialYasuhiro Kondoh, Arata Azuma, Yoshikazu Inoue, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 11, 2019
JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis　- Digest VersionFumio Terasaki, Arata Azuma, Toshihisa Anzai, et al.
Scientific Reports|December 27, 2023
A prospective cohort study of periostin as a serum biomarker in patients with idiopathic pulmonary fibrosis treated with nintedanibMasaki Okamoto, Kiminori Fujimoto, Takeshi Johkoh, et al.
Respiratory Investigation|March 18, 2025
Prognostic prediction for newly diagnosed patients with idiopathic interstitial pneumonia: JIPS Registry (NEJ030)Ryo Okuda, Takashi Ogura, Shu Hisata, et al.
Pageof 23